Brief: Agile Therapeutics Inc - On Nov 9, Received A Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
12/11/2021 21:49
Nov 12 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS INC - ON NOV 9, RECEIVED A NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
* AGILE THERAPEUTICS INC - CO HAS BEEN PROVIDED AN INITIAL
PERIOD
UNTIL MAY 9, 2022 TO REGAIN COMPLIANCE WITH BID PRICE
REQUIREMENT
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt